MELINTA THERAPEUTICS, INC. /NEW/ — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/faee69ee-751e-4941-8fea-a41019d3254f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-158.4M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002907 |
| FY 2017 | $-78.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005947 |
| FY 2016 | $-69.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-005947 |
| FY 2015 | $-76.9M | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-005947 |
| FY 2014 | $-59.4M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-002719 |
| FY 2013 | $-42.9M | 2013-01-01 – 2013-12-31 | evidence 0001564590-14-000446 |
| FY 2012 | $-115.3M | 2005-11-17 – 2013-03-31 | evidence 0001193125-13-174054 |
| FY 2011 | $-85.2M | 2005-11-18 – 2012-03-31 | evidence 0001193125-12-225467 |
| FY 2010 | $-18.7M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-096011 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MELINTA THERAPEUTICS, INC. /NEW/ — all facts · Revenue · Net Income